BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21525574)

  • 1. Soluble interleukine-2 receptor and MDR1 gene expression levels as inflammatory biomarkers for prediction of steroid response in children with nephrotic syndrome.
    Youssef DM; Elbehidy RM; Abdelhalim HS; Amr GE
    Iran J Kidney Dis; 2011 Jul; 5(3):154-61. PubMed ID: 21525574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.
    Youssef DM; Attia TA; El-Shal AS; Abduelometty FA
    Gene; 2013 Nov; 530(2):201-7. PubMed ID: 23994685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome.
    Ece A; Atamer Y; Gürkan F; Bilici M; Koçyiğit Y
    Nephrology (Carlton); 2004 Dec; 9(6):366-73. PubMed ID: 15663638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPC6 gene variants in Turkish children with steroid-resistant nephrotic syndrome.
    Mir S; Yavascan O; Berdeli A; Sozeri B
    Nephrol Dial Transplant; 2012 Jan; 27(1):205-9. PubMed ID: 21511817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children.
    Jafar T; Prasad N; Agarwal V; Mahdi A; Gupta A; Sharma RK; Negi MP; Agrawal S
    Nephrol Dial Transplant; 2011 Dec; 26(12):3968-74. PubMed ID: 21460357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of blood soluble and cell surface tumor necrosis factor receptors in childhood nephrotic syndrome.
    Tain YL; Liu CA; Yang KD
    Pediatr Nephrol; 2002 Nov; 17(11):926-32. PubMed ID: 12432436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance to therapy in primary nephrotic syndrome: effect of MDR1 gene activity].
    Stachowski J; Zanker CB; Runowski D; Zaniew M; Peszko A; Medyńska A; Zwolińska D; Rogowska-Kalisz A; Hyla-Klekot L; Szprygner K; Weglarska J; Sieniawska M; Musiał W; Maciejewski J; Baldamus CA
    Pol Merkur Lekarski; 2000 Apr; 8(46):218-21. PubMed ID: 10897619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of the treatment of steroid-resistant and steroid-dependent nephrotic syndrome with pulsed doses of prednisolone].
    Gura C; Pałka L; Pańczyk-Tomaszewska M; Sieniawska M; Pazdur J
    Wiad Lek; 1992 May; 45(9-10):343-8. PubMed ID: 1441541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptors and the pattern of steroid response in idiopathic nephrotic syndrome.
    Shalaby SA; El Idrissy HM; Safar RA; Hussein ST
    Arab J Nephrol Transplant; 2012 Jan; 5(1):13-7. PubMed ID: 22283861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood.
    Neuhaus TJ; Shah V; Callard RE; Barratt TM
    Nephrol Dial Transplant; 1995; 10(8):1348-52. PubMed ID: 8538925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-18 expression in peripheral blood mononuclear cells in children with steroid-resistant nephrotic syndrome].
    Jiang HK; Luo G; Jiang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):337-40. PubMed ID: 19470251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F; Ahmad TM; Anwar S
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple drug-resistant gene 1 in children with steroid-sensitive nephrotic syndrome.
    Funaki S; Takahashi S; Wada N; Murakami H; Harada K
    Pediatr Int; 2008 Apr; 50(2):159-61. PubMed ID: 18353050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
    J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P; Jesdapatarakul S
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of steroid resistant nephrotic syndrome in children.
    Kari JA; Halawani M
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of steroid-resistant nephrotic syndrome in children.
    Otukesh H; Otukesh S; Mojtahedzadeh M; Hoseini R; Fereshtehnejad SM; Riahi Fard A; Sadigh N; Heshmatzade Behzadi A; Javadi R; Hooman N; Mehrazma M
    Iran J Kidney Dis; 2009 Oct; 3(4):210-7. PubMed ID: 19841524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.